Video

Did you know: Dr. David Henry reports from ASH


 

Dr. David Henry, editor-in-chief of Community Oncology, shares some of his "did you know" picks from the annual meeting of the American Society of Hematology. His 5-minute report reviews the new international prognostic scoring system for myelodysplastic syndromes, gene expression profiling for diffuse large b-cell lymphoma, an approach to Waldenstrom’s macroglobulin anemia, gray zone lymphoma, multiple myeloma updates, and more.

Recommended Reading

With Ponatinib, CML Resistance Is Squashed - For Now
MDedge Hematology and Oncology
Fewer Deaths with Tighter Hematocrit Target in Polycythemia Vera
MDedge Hematology and Oncology
HEM-ONC CHAT: Dr. Elias Jabbour, 'Treatment a la Carte in CML'
MDedge Hematology and Oncology
Experimental quizartinib gives bridge to transplant in relapsed AML
MDedge Hematology and Oncology
Targeting new myeloma pathway pays off with ARRY-520
MDedge Hematology and Oncology
FDA approves ponatinib for CML and Ph-positive ALL
MDedge Hematology and Oncology
Chemo-free combo tames 'worst of the worst' acute leukemia
MDedge Hematology and Oncology
TOPPS: Limit prophylactic platelets to select groups
MDedge Hematology and Oncology
Double-unit cord blood transplants don't boost survival
MDedge Hematology and Oncology
Live from ASH: Dr. David Henry shares his 'did you know' picks
MDedge Hematology and Oncology